TWD 65.1
(-0.61%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 173.54 Million TWD | -46.85% |
2022 | 369.66 Million TWD | -7.22% |
2021 | 398.42 Million TWD | 16.1% |
2020 | 343.17 Million TWD | 110.4% |
2019 | 163.1 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 15.49 Million TWD | 0.0% |
2024 Q1 | 15.49 Million TWD | 12.98% |
2023 Q3 | 13.71 Million TWD | -81.22% |
2023 FY | 196.49 Million TWD | -46.85% |
2023 Q2 | 73.05 Million TWD | 0.0% |
2023 Q1 | 73.05 Million TWD | -21.67% |
2023 Q4 | 13.71 Million TWD | 0.0% |
2022 FY | 369.66 Million TWD | -7.22% |
2022 Q4 | 93.26 Million TWD | 0.0% |
2022 Q3 | 93.26 Million TWD | 0.0% |
2021 FY | 398.42 Million TWD | 16.1% |
2020 FY | 343.17 Million TWD | 110.4% |
2019 FY | 163.1 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | -95.628% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | -13.013% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | 206.643% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 87.355% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 71.769% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | -105.252% |
Center Laboratories, Inc. | -79.26 Million TWD | 318.948% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | -749.232% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | -525.334% |
InnoPharmax Inc. | -64.83 Million TWD | 367.661% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | -64.391% |
Excelsior Biopharma Inc. | -81.12 Million TWD | 313.92% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 117.224% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 75.057% |
UniPharma Co., Ltd. | -27.3 Million TWD | 735.594% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | -226.508% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 54.984% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | 11.5% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | 479.84% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | 997.776% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | -172.747% |